Task: Answer the multiple-choice question.
Question: Which drug exhibits a 8.422\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1ccc(CCNC(=O)c2cc(S(=O)(=O)N3CCCCC3)c[nH]2)cc1
b.) CCCn1c(SC(C(=O)Nc2cc(C)ccc2OC)c2ccccc2)nc2ccccc2c1=O
Answer: b. CCCn1c(SC(C(=O)Nc2cc(C)ccc2OC)c2ccccc2)nc2ccccc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(SC(C(=O)Nc2cc(C)ccc2OC)c2ccccc2)nc2ccccc2c1=O
CCCn1c(SC(C(=O)Nc2cc(C)ccc2OC)c2ccccc2)nc2ccccc2c1=O
N-(2-methoxy-5-methylphenyl)-2-(4-oxo-3-propylquinazolin-2-yl)sulfanyl-2-phenylacetamide